Wegovy weight loss pill to hit Australian chemist shelves

Resumen detallado
Australians who have relied solely on weight loss injections will now have a new pill option, but it comes with a warning.
A new weight loss pill will be hitting shelves on Friday in an Australia-first shift away from injection-only weight loss treatments.
The Therapeutic Goods Administration (TGA) recently approved the production and sale of Wegovy GLP-1 pills in Australia, with retailers revealing they expect them to be widely available at chemists.
RACGP President Michael Wright said it was crucial people consulted their GPs before purchasing the pills.
“It’s a small molecule medication, not a peptide – and this means it’s better absorbed orally and not breaking down in the stomach,” Dr Wright told newsGP.
“GLP-1 agonists can be well tolerated. They’re effective, but they’re not for everyone and GPs are the best practitioner to help people understand what might be the best option for them,” he said.
Australia is the latest country to approve Wegovy in pill form, with the Novo Nordisk-manufactured drug currently available for purchase in chemists across the US and UK.
Until now, Wegovy and other weight loss drugs like Ozempic and Mounjaro have only been available as injections in Australia.
For the drug to work properly, users are required to take the tablet on an empty stomach first thing in the morning with half a cup of water.
Federal health officials have been pushing to get weight loss drugs on the Pharmaceutical Benefits Scheme (PBS) so Australians don’t have to fork out huge amounts of cash to access the products.
Inicio del artículo, extracto de PerthNow. Para leer el resto, abra el artículo en el sitio del medio.
MarketNews muestra el titular y el resumen publicados por el medio. El artículo completo se lee en el sitio del editor. (www.perthnow.com.au)



